𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

✍ Scribed by J. A. Henry; Anne L. McCarthy; B. Angus; B. R. Westley; Felicity E. B. May; S. Nicholson; J. Cairns; A. L. Harris; C. H. W. Horne


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
648 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Flow cytometry and quantitative immunohi
✍ Jean-Jacques Michels; FranΓ§oise Duigou; Jacques Marnay; Michel Henry-Amar; Thier πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 269 KB

## Background: Between january 11, 1991 and january 8, 1992, 104 patients with previously untreated, invasive, primitive breast carcinoma were admitted to the authors' hospital. ## Methods: For each patient, flow cytometry dna analyses on frozen samples and on immunohistochemical staining were pe

A prospective study of the prognostic va
✍ Pascal Pujol; Thierry Maudelonde; Jean-Pierre Daures; Philippe Rouanet; Jean-Pau πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 545 KB

Background. Cathepsin D is a lysosomal protease overexpressed and abnormally secreted in most breast cancer cells. Several retrospective clinical studies have shown that cathepsin D is an independent prognostic factor in breast cancer that is associated with a higher risk of recurrence and a shorter

Evaluation of the prognostic significanc
✍ Gunnar B. Kristensen; Ruth Holm; Vera M. Abeler; Claes G. TropΓ© πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 700 KB

BACKGROUND. This study evaluated the prognostic significance of immunohistochemical staining for cathepsin D, epidermal growth factor receptor (EGFR). and c-erbB-2 in patients with early cervical squamous cell carcinoma. ## METHODS. This retrospective analysis comprised 132 patients, all subjecte

Estrogen receptors (ER) in human breast
✍ Marianne Gotteland; Evelyne May; FranΓ§oise May-Levin; GeneviΓ¨ve Contesso; Jean-C πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 843 KB

Background. The response to endocrine therapy is not entirely predictable from the estrogen receptor (ER) and progesterone receptor (PgR) status of primary breast tumors. The authors previously proposed a new prognostic factor, ER.R, which was based on both ER protein and mRNA levels. A previous ana

Modulation of the estrogen-regulated pro
✍ Simone Panagiotou; Anastassia Hatzoglou; Fabien Calvo; Pierre-Marie Martin; Elia πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 273 KB πŸ‘ 3 views

In many cancer cell lines, including breast, prostate, lung, brain, head and neck, retina, and the gastrointestinal tract, opioids decrease cell proliferation in a dose-dependent and reversible manner. Opioid and/or other neuropeptide receptors mediate this decrease. We report that only the steroid-